Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.47 |
| ▸ | DGKA | P23743 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | NAAA | Q02083 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | PAM | P19021 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27487514 | 1.00 | LMNA (0.47) | LMNADGKAMAPTMAPK1RAB9A | |
| SCHEMBL21603056 | 1.00 | LMNA (0.47) | LMNADGKAMAPTMAPK1RAB9A | |
| SCHEMBL324685 | 1.00 | LMNA (0.47) | LMNADGKAMAPTMAPK1RAB9A | |
| SCHEMBL323833 | 1.00 | LMNA (0.47) | LMNADGKAMAPTMAPK1RAB9A | |
| SCHEMBL11650239 | 1.00 | LMNA (0.47) | LMNADGKAMAPTMAPK1RAB9A | |
| SCHEMBL7158840 | 1.00 | LMNA (0.47) | LMNADGKAMAPTMAPK1RAB9A | |
| SCHEMBL324052 | 1.00 | LMNA (0.47) | LMNADGKAMAPTMAPK1RAB9A | |
| SCHEMBL8526268 | 0.93 | RAB9A (0.46) | LMNAMAPTRAB9AL3MBTL1GLA | |
| SCHEMBL21522573 | 0.91 | CNR1 (0.51) | LMNADGKAMAPTPOLBDUSP3 | |
| SCHEMBL324745 | 0.91 | CNR1 (0.51) | LMNADGKAMAPTPOLBDUSP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 310 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190099342-A1 | COOLING PRODUCT | SYMRISE AG (DE) | 2019-04-04 | — | — | US | claimed |
| US-4525502-A | AMMONIUM OR AMINE SALT OF CARBOXYLIC ACID AS EMULSIFIER FOR POLYSILOXANES; WATERPROOFING; MASONRY | GENERAL ELECTRIC COMPANY (US) | 1985-06-25 | — | — | US | claimed |
| US-4171388-A | Magnetic recording and storage device having high abrasion resistance and method | CORNING GLASS WORKS (US) | 1979-10-16 | — | — | US | claimed |
| US-4171399-A | Magnetic recording and storage device having high abrasion resistance and method | CORNING GLASS WORKS (US) | 1979-10-16 | — | — | US | claimed |
| US-4152469-A | Method of forming a magnetic recording and storage device having high abrasion resistance | CORNING GLASS WORKS (US) | 1979-05-01 | — | — | US | claimed |
| WO-2026087745-A1 | AN ANTIOXIDANT COMPOSITION COMPRISING A CINNAMIC ACID DERIVATIVE | BRAIN Biotech AG (DE) | 2026-04-30 | — | — | WO | disclosed |
| EP-4732825-A1 | AN ANTIOXIDANT COMPOSITION COMPRISING A CINNAMIC ACID DERIVATIVE | BRAIN Biotech AG (DE) | 2026-04-29 | — | — | EP | disclosed |
| US-20260096978-A1 | A METHOD FOR PREVENTING, MITIGATING AND/OR TREATING PTGS2-INDUCED SKIN DISORDERS AND RELATED DYSFUNCTIONS | SYMRISE AG (DE) | 2026-04-09 | — | — | US | disclosed |
| EP-4025675-B1 | A PERFUME OIL MIXTURE | SYMRISE AG (DE) | 2026-03-18 | — | — | EP | disclosed |
| US-20260047994-A1 | AN ACTIVE COMPOSITION COMPRISING RETINOL | SYMRISE AG (DE) | 2026-02-19 | — | — | US | disclosed |
| US-20260041094-A1 | Compositions Comprising an Antimicrobial Boosting Agent | SYMRISE AG (DE) | 2026-02-12 | — | — | US | disclosed |
| EP-4687810-A1 | PREPARATIONS COMPRISING HYDROXY PINACOLONE RETINOATE | Symrise AG (DE) | 2026-02-11 | — | — | EP | disclosed |
| US-4502540-A | Tertiary oil recovery | MOBIL OIL CORPORATION (US) | 1985-03-05 | — | — | US | disclosed |
| US-4337288-A | WITH CONTROLLED SURFACE ROUGHNESS | FUJI PHOTO FILM CO., LTD. (JP) | 1982-06-29 | — | — | US | disclosed |
| US-4303738-A | Magnetic media having tridecyl stearate lubricant | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 1981-12-01 | — | — | US | disclosed |
| US-4253886-A | Corrosion resistant ferromagnetic metal powders and method of preparing the same | FUJI PHOTO FILM CO., LTD. (JP) | 1981-03-03 | — | — | US | disclosed |
| US-4171388-A | Magnetic recording and storage device having high abrasion resistance and method | CORNING GLASS WORKS (US) | 1979-10-16 | — | — | US | disclosed |
| US-4171399-A | Magnetic recording and storage device having high abrasion resistance and method | CORNING GLASS WORKS (US) | 1979-10-16 | — | — | US | disclosed |
| US-4152469-A | Method of forming a magnetic recording and storage device having high abrasion resistance | CORNING GLASS WORKS (US) | 1979-05-01 | — | — | US | disclosed |
| US-3971439-A | Designing micellar displacement systems to minimize adsorption | MARATHON OIL COMPANY (US) | 1976-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190099342-A1 | COOLING PRODUCT | TRPA1, TRPV2, NISCH | LMNA 2013/4885DGKA 550/4885MAPT 1951/4885 |
| US-20260041094-A1 | Compositions Comprising an Antimicrobial Boosting Agent | TLR7, MYC, ERG28 | LMNA 4342/4885DGKA 2284/4885MAPT 4723/4885 |
| US-20260047994-A1 | AN ACTIVE COMPOSITION COMPRISING RETINOL | RBP4, LRAT, RARB | LMNA 2563/4885DGKA 121/4885MAPT 781/4885 |
| US-20260096978-A1 | A METHOD FOR PREVENTING, MITIGATING AND/OR TREATING PTGS2-INDUCED SKIN DISORDERS AND RELATED DYSFUNCTIONS | PTGS2, PTGES2, PTGS1 | LMNA 2747/4885DGKA 3138/4885MAPT 4406/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.